Concepedia

Vandana G. Abramson

VG

Statistics

Publications

100

Citations

10.8K

H-Index

48

Active since

2008

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Dana-Farber Cancer Institute

Vanderbilt-Ingram Cancer Center

University of North Carolina at Chapel Hill

Vandana G. Abramson is an author at Vanderbilt University specializing in oncology, medicine, and breast oncology.

Publications per year

2008–2025

100

Publications

100

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Rashmi K. Murthy, Sherene Loi, Alicia Okines et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +12

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat et al. · New England Journal of Medicine · 2019 · 850 citations

Medicine, Oncology, Pharmacology +17

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

Vandana G. Abramson, Andrea B. Troxel, Anoma Nellore et al. · Journal of Clinical Oncology · 2008 · 679 citations · Full text

Medicine, Oncology, Pharmacology +6

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

William J. Gradishar, Meena S. Moran, Jame Abraham et al. · Journal of the National Comprehensive Cancer Network · 2024 · 560 citations

Medicine, Oncology, Radiation Oncology +17

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

Nancy U. Lin, Virginia F. Borges, Carey K. Anders et al. · Journal of Clinical Oncology · 2020 · 549 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 100